Cisplatin (Alvogen Inc.)
Welcome to the PulseAid listing for the Cisplatin drug offered from Alvogen Inc.. This Platinum-based Drug [EPC],Platinum-containing Compounds [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Alvogen Inc. |
| NON-PROPRIETARY NAME: | cisplatin |
| SUBSTANCE NAME: | CISPLATIN |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Platinum-based Drug [EPC],Platinum-containing Compounds [Chemical/Ingredient] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2017-09-25 |
| END MARKETING DATE: | 0000-00-00 |
Cisplatin HUMAN PRESCRIPTION DRUG Details:
| Item Description | Cisplatin from Alvogen Inc. |
| LABELER NAME: | Alvogen Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 50(mg/50mL) |
| START MARKETING DATE: | 2017-09-25 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 47781-609_88e08beb-d19a-d59f-c1b2-c9990f8a12a9 |
| PRODUCT NDC: | 47781-609 |
| APPLICATION NUMBER: | ANDA207323 |
Other CISPLATIN Pharmaceutical Manufacturers / Labelers:
